Deepak Sapra Resigns As CEO, API & Services At Dr. Reddy’s Laboratories

Deepak Sapra has resigned from the position of Chief Executive Officer (CEO) of API & Services and Senior Management Personnel (SMP) of Dr. Reddy’s Laboratories Limited to pursue opportunities outside the Company, effective November 12, 2026.

Sapra is a pharmaceutical industry executive who is serving as CEO of the Pharmaceutical Services and Active Ingredients (PSAI) business at Dr. Reddy’s Laboratories. His responsibilities included the company’s API business, Aurigene Pharmaceutical Services (APSL), public health initiatives, and B2B collaborations.  He published his first book in 2018 and co-founded a charitable trust supporting people with disabilities in eastern India. He joined Dr. Reddy’s in 2003 after completing his studies at IIM Bangalore and has held roles across marketing, sales, business development and portfolio management, covering international markets. Sapra has been a Fulbright fellow and Chevening scholar.

a

Magazine made for you.